Molecular Partners AG stock forecast
Molecular Partners AG (MLLCF) Stock Forecast & Price Target
MLLCF Analyst Ratings
MLLCF Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Michael Nedelcovych | TD Cowen | $17.79 | buy | 343.63%Upside | Reiterated | 03/16/26 | ||
| Richard Vosser | J.P. Morgan | $4.74→$3.56 | hold | -11.27%Downside | Reiterated | 12/08/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Michael NedelcovychTD Cowen | BuyReiterated$17.79 | 03/16/26 | 343.63%Upside | ||
| Richard VosserJ.P. Morgan | HoldReiterated$4.74→$3.56 | 12/08/25 | -11.27%Downside |
Best Analysts Covering Molecular Partners AG
Copying Michael Nedelcovych's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of +22.78% per trade.
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -1.94% per trade.
Copying Michael Nedelcovych's trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of +2.02% per trade.
MLLCF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, MLLCF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MLLCF average Analyst price target in the past 3 months is ―.
MLLCF Financial Forecast
MLLCF Earnings Forecast
Next quarter’s earnings estimate for MLLCF is -$0.43 with a range of -$0.46 to -$0.40. The previous quarter’s EPS was -$0.42. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
MLLCF Sales Forecast
Next quarter’s sales forecast for MLLCF is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

